Case Reports in Infectious Diseases
Volume 2015 (2015), Article ID 132317, 5 pages
http://dx.doi.org/10.1155/2015/132317

Case Report

Case Report of Granulicatella adiacens as a Cause of Bacterascites

Molly C. Cincotta,¹ K. C. Coffey,² Shannon N. Moonah,³ Dushant Uppal,⁴ and Molly A. Hughes³

¹School of Medicine, University of Virginia, Charlottesville, VA 22908, USA
²Department of Medicine, University of Virginia, Charlottesville, VA 22908, USA
³Division of Infectious Diseases, Department of Medicine, University of Virginia, Charlottesville, VA 22908, USA
⁴Division of Gastroenterology, Department of Medicine, University of Virginia, Charlottesville, VA 22908, USA

Received 29 July 2015; Revised 16 October 2015; Accepted 19 October 2015

Academic Editor: Paola Di Carlo

Copyright © 2015 Molly C. Cincotta et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Granulicatella adiacens is a Gram-positive coccus, formerly grouped with nutritionally variant Streptococcus, often found as commensal bacteria of the human oral cavity, urogenital tract, and gastrointestinal tract. Prior case reports have demonstrated Granulicatella spp. as a pathogen that can cause bacteremia and infective endocarditis particularly of prosthetic valves and pacemaker leads. Here, we report on a unique case of Granulicatella adiacens bacterascites in a 50-year-old male.

1. Introduction

Granulicatella adiacens is a Gram-positive coccus that is nonmotile, nonsporulating, catalase-negative, oxidase-negative, and facultatively anaerobic. G. adiacens often grows on agar as satellite colonies adjacent to another organism that provides nutrients such as Staphylococcus aureus or Staphylococcus epidermidis [1, 2]. G. adiacens colonies are alpha-hemolytic on sheep-blood agar [1]. The organism has been found to be resistant to optochin and susceptible to vancomycin [1]. The genus Granulicatella has three species, G. adiacens, G. elegans, and G. balaenopterae, with only the former two having been isolated from human samples [2]. Granulicatella species are an uncommon cause of infection. To date, there have been no described cases of Granulicatella adiacens as a cause of spontaneous bacterial peritonitis or as an isolate of ascites fluid.

2. Case Report

2.1. History

A 50-year-old man presented to the emergency department (ED) complaining of symptomatic large volume ascites. The patient and his ascites had been followed by his PCP, who had been adjusting diuretics. However, the patient was failing diuretic management and so was referred to our hospital for a therapeutic paracentesis. The patient’s past medical history was significant for a complicated course of gallstone pancreatitis that occurred eight months prior to his current presentation. Chart review revealed several prolonged hospital courses, totaling 53 hospital days, with multiple complications, including necrotizing pancreatitis status after necrosectomy and cholecystectomy, interval placement and subsequent removal of a percutaneous endoscopic gastrostomy tube with jejunal arm (PEG-J) for enteral feeding, Clostridium difficile diarrheal infection for which he had received fourteen days of treatment with oral metronidazole, and a new diagnosis of diabetes mellitus. Additionally, he had been found to have new portal vein and splenic vein thromboses during that hospitalization and had since completed six months of therapeutic anticoagulation, originally with Apixaban, which was later switched to Rivaroxaban.

At the time of the patient’s current presentation for ascites, most of the above medical problems had resolved. He was tolerating a regular diet and was being followed by his PCP for management of recurrent ascites felt to be due to the above-mentioned portal vein thrombosis.

The patient reported no symptoms other than decreased appetite secondary to bloating and pain in his right groin likely from nonincarcerated hernia. He had no fever, shortness of breath, nausea, vomiting, diarrhea, or significant constipation.

Upon presentation to the ED, computed tomography (CT) of the abdomen showed large volume ascites with no propagation of the portal vein or splenic vein thromboses with interim development of collaterals.

2.2. Physical Examination

On exam, the patient’s heart rate was normal with a regular rhythm, his lungs were clear, and there was no lower extremity edema. His abdomen was significantly distended, with bulging flanks and a palpable fluid wave. There was a well-healed midline surgical scar with a distal keloid and easily reducible umbilical hernia. Aside from the ascites, the patient had no other sequelae of chronic liver dysfunction; he exhibited no jaundice, no palmar erythema, no spider angiomata, no venous distention, and no asterixis.

2.3. Laboratory and Radiological Investigations

In the ED, the patient underwent paracentesis by the gastroenterology (GI) team under normal sterile technique with removal of approximately 4.5 L of clear, yellow fluid. Initial Gram stain of the ascites fluid revealed white blood cells and no bacteria. Pertinent fluid analyses revealed glucose 100 mg/dL, amylase 52 U/L, WBC 372/UL with 48% polymorphonuclear cells (PMNs) and 24% lymphocytes, total protein 4.2 g/dL, and albumin 2.1 g/dL giving a serum albumin ascites gradient of 1.5, consistent with portal hypertension or congestive heart failure. Blood work revealed a peripheral white blood cell count of 6.85 k/L with a normal differential, platelet count of 326 k/L, and a lactic acid of 1.3 mmol/L. Ultrasound of the abdomen confirmed that there was no interim propagation of the portal vein thrombosis as well as presence of patent collaterals.

2.4. Hospital Course

The patient was discharged from the ED with a follow-up outpatient appointment with a GI physician for further evaluation and management of recurrent ascites. The following day, the GI team was contacted by the Clinical Microbiology Laboratory that Gram-positive cocci in chains were growing in the ascites sample. The GI team contacted the patient’s wife who reported that the patient had experienced no clinical status change since the procedure, specifically no fevers or abdominal pain.

The GI team felt that the laboratory result likely represented a contaminant in the sample, and they decided to await speciation before asking the patient to return to the hospital. The following day, the Clinical Microbiology Laboratory reported Granulicatella adiacens (not a common laboratory contaminant), so the patient was asked to return to the hospital to be admitted for further monitoring and evaluation.

Upon return to the hospital, the patient reported interval improvement in his abdominal bloating and appetite, and he denied any new symptoms, including fever, abdominal pain, nausea, or diarrhea. His exam was unchanged from prior exam aside from a decrease in his abdominal distention. The GI team performed a diagnostic paracentesis, which revealed glucose of 135 mg/dL, WBC of 813/UL with 72% lymphocytes, 1% PMNs, and 2% atypical lymphocytes, total protein of 4.3 g/dL, and albumin of 2.1 g/dL. Ascites fluid again showed 3+ white blood cells and the bacterial culture again grew Granulicatella adiacens. Peripheral blood cultures from two separate peripheral sites were collected and showed no growth after 72 hours. Blood work was not significantly changed from the first presentation.

The patient underwent a transthoracic echocardiogram that showed no evidence of structural cardiac defect and no evidence of endocarditis. His previous CT was reexamined and a large fluid collection was seen with a possible rim of residual pancreatic tissue. Based on this, a magnetic resonance cholangiopancreatography (MRCP) was performed that revealed a fluid collection with possible communication to the left colon. The GI team consulted the general surgery team, who, on review of the imaging and patient status, felt that the risks associated with any surgical intervention outweighed the potential benefits of source control.

Due to the patient having a penicillin allergy, he received intravenous vancomycin for his course of therapy. The five-day antibiotic course was initially complicated by an infusion-related “red man” reaction requiring pretreatment with diphenhydramine and slower infusion times. On hospital day 3, a peripherally inserted central venous catheter (PICC) line was placed, and the patient was discharged home in stable condition. The patient underwent colonoscopy one month later and was found to have three hyperplastic polyps without evidence of malignancy. There was no apparent communication between the colon and the fluid pocket that had been visualized on MRCP. No further blood or ascites cultures were collected in the immediate period after his hospitalization.

3. Discussion

Granulicatella adiacens is an uncommon cause of infection, but when present, it is most commonly found in the bloodstream. Review of the English literature shows that bacteremia is usually related to device/graft infection or endocarditis (Table 1). Cargill et al. described 17 cases of Granulicatella spp. endocarditis between 1997 and 2012 including infections of prosthetic valves and a pacemaker lead [2]. It is suspected that cases of Granulicatella spp. infective endocarditis are underreported and that some cases may be a cause of reported culture-negative endocarditis. Bacteremia with Granulicatella spp.without endocarditis has been reported, including a single case of infection of aortic atheroma with associated dissection [2]. Other infections have included seeding by prosthetic material or surgery with isolates from brain abscess, CSF, joint space, vertebrae, and breast implant [2].

Table 1: Clinical characteristics of other cases of Granulicatella adiacens reported in the English literature in PubMed.

Age (years)/gender
Site of infection
Antibiotic treatment
Treatment duration (weeks)
Outcome
Reference

58/M
Mitral valve
Vancomycin/gentamicin
NS
Survived
[2]

63/M
Mitral and aortic valves
Amoxicillin/gentamicin
NS
Survived
[2]

38/F
Tricuspid valve
Amoxicillin/gentamicin
NS
Survived
[2]

63/F
Mitral and tricuspid valves
Amoxicillin/gentamicin
NS
Deceased
[2]

71/F
Aortic valve
Penicillin/gentamicin
6
Survived
[2]

31/M
Mitral valve
Oxacillin/gentamicin
NS
Survived
[3]

18/M
Pulmonic valve
Vancomycin/gentamicin/rifampin
6
Survived
[4]

18/F
Mitral valve
Penicillin/gentamicin
NS
Survived
[5]

61/M
Mitral and tricuspid valves
Penicillin/gentamicin
NS
Survived
[5]

30/M
Mitral valve
Penicillin/gentamicin/ceftriaxone
NS
Survived
[5]

28/F
Mitral and aortic valves
Penicillin/gentamicin/vancomycin/teicoplanin
NS
Survived
[5]

57/M
Endocarditis, valve unknown
Ampicillin/gentamicin
2
Survived
[6]

77/F
Aortic valve
Vancomycin/ampicillin/gentamicin
NS
Survived
[2]

68/M
Pacemaker/vertebral osteomyelitis
Penicillin/gentamicin/rifampin
NS
Survived
[7]

41/M
Mitral and aortic valve
Penicillin/gentamicin
NS
Survived
[2]

85/M
Endocarditis, valve not reported
NS
NS
Deceased
[2]

71/M
Mitral valve
Ampicillin/gentamicin
5
Survived
[8]

48/F
Mitral valve
Ceftriaxone/gentamicin
4
Survived
[9]

50/M
Mitral and aortic valve
Penicillin/gentamicin
6
Survived
[10]

63/M
Mitral valve
Ampicillin/gentamicin
4
Survived
[11]

0/M
Sepsis
Vancomycin
2
Survived
[12]

NS
Abdominal aortic graft
NS
NS
Deceased
[2]

NS
Hemodialysis catheter
Vancomycin
NS
Survived
[2]

55/F
Peritonitis
Cefazolin/gentamicin
2
Survived
[13]

32/F
Meningitis postsurgical
Penicillin/gentamicin
4/2
Survived
[14]

53/F
Meningitis postsurgical
Penicillin/gentamicin
4
Survived
[14]

49/F
Meningitis after myelography
Vancomycin/fosfomycin/cefixime/rifampin
1.5
Survived
[14]

2/F
Brain abscess
Ampicillin/rifampin/gentamicin
4.5/4.5/1
Survived
[14]

46/F
Brain abscess postsurgical
Ceftriaxone/gentamicin
1.5
Survived
[15]

32/F
Breast implant
Rifampin/amoxicillin
4 months
Survived
[16]

73/M
Bacteremia/vertebral osteomyelitis
Penicillin/gentamicin
4 months
Survived
[17]

68/F
Knee joint
Cefazolin/gentamicin
4/2
Survived
[18]

46/F
Chronic dacryocystitis
Cephalexin/erythromycin/tobramycin-dexamethasone drops
5 days
Survived
[19]

57/M
Aortic valve
Benzylpenicillin
6
Survived
[20]

55/M
Prosthetic knee
Amoxicillin/rifampin
3 months
Survived
[21]

56/M
Scapular carbuncle
Amoxicillin-clavulanate
NS
Survived
[22]

89/F
Posttraumatic bacteremia
Cefazolin
NS
Survived
[23]

Neonate; NS: not specified; with permanent neurological sequelae.

To our knowledge, we are the first to report a case of G. adiacens as a cause of monomicrobial nonneutrocytic bacterascites. Bacterascites is thought to represent colonization of ascites fluid and may progress to the life threatening complication of spontaneous bacterial peritonitis (SBP). The pathogens related to bacterascites are similar to SBP; however the diagnosis of SBP requires the presence of >/= 250 PMN cells/mm³ in addition to a positive Gram stain and/or culture of the ascitic fluid [24, 25]. The pathogenesis of SBP is thought to be directly related to hepatic dysfunction, with portal hypertension and local intestinal immunodeficiency leading to intestinal bacterial overgrowth and intestinal mucosal edema leading to breakdown of the epithelial barrier and increased permeability, which can allow for bacterial translocation to other tissues. In patients with ascites fluid that contains protein levels <1 g/dL and/or C3 levels < 13 mg/dL, there is a predisposition for infection [24].

Notably, Altay et al. described a case of G. adiacens bacterial peritonitis in a 55-year-old woman, but this was thought to be a peritoneal dialysis-related infection [13]. In that case, the patient was being treated empirically with intraperitoneal cefazolin and gentamicin when repeat cultures of the dialysate grew a single colony of G. adiacens susceptible to the empiric regimen. The patient completed 14 days of antibiotic therapy and showed clinical improvement after 2 days with concomitant decrease in ascites leukocytosis [13].

The origin of G. adiacens in our patient remains unclear. The possibility of an occult colon cancer leading to bacterial translocation, akin to Streptococcus bovis, was considered, but as colonoscopy was unrevealing for malignancy, this is unlikely. As discussed above, CT and MRCP of the abdomen demonstrated a fluid collection near the tail of the pancreas that may have communicated with the wall of the descending colon. Although subsequent colonoscopy did not show evidence of a direct communication, such an area of weakness in the gut wall may have been susceptible to earlier bacterial translocation.

Granulicatella spp., when not seen as a causative agent in infective endocarditis or other endovascular infections or bacteremia, have been associated with surgical intervention or seeding from a prosthesis [2]. As this patient had prior extensive abdominal surgery, it is possible that the original introduction of G. adiacens occurred during surgery and simply went undetected due to his lack of symptoms. This possibility seems less likely given that the patient had undergone one previous paracentesis several months earlier that grew no organism; however G. adiacens is not easily detected and has been found in peritoneal fluid previously documented as culture-negative [13]. It remains questionable whether the presence of Granulicatella spp. bacterascites was clinically significant, given the patient’s failure to develop peritonitis.

The question of asymptomatic bacterascites is controversial as to whether it may be an incidental finding in patients without laboratory diagnosis of spontaneous bacterial peritonitis. The tendency is to err on the side of treatment in these cases. Older data show that, in patients with nonneutrocytic monomicrobial bacterascites, 62% (65/105) became sterile without antimicrobial intervention. The remaining 38% progressed to SBP [24]. The current recommendations for antibiotic treatment of and prophylaxis against SBP are targeted toward patients with cirrhosis and low ascites protein levels, neither of which describes this patient [25]. With respect to Granulicatella spp. as a causative agent, more data would be necessary to draw conclusions regarding the pathogenicity of this particular organism in ascites fluid. Limitations of earlier data are subject to the nutritionally variable nature of this organism, as its prior eponym suggests. Fortunately, 16s rRNA sequencing and mass spectrometry are becoming increasingly more common diagnostic tools, in some cases replacing traditional culture, which often confused this organism with poorly growing Streptococcus.

Our patient was treated with a 5-day course of intravenous vancomycin although Granulicatella adiacens infections have most commonly been treated with a beta-lactam antibiotic (Table 1). Intravenous vancomycin was chosen in this case because the patient had a penicillin allergy. Additionally, antibiotic susceptibility testing could not be performed for this isolate so beta-lactam antibiotic susceptibility or resistance could not be assessed. A limitation of our report is that successful eradication was not definitively demonstrated, as repeat paracentesis was not performed because the patient was doing well clinically, and our patient was asymptomatic prior to initiation of microbial therapy. Contamination is not suspected, as the organism grew from two separate cultures, obtained two days apart. If our patient manifests symptoms or if future blood or ascites fluid cultures grow Granulicatella spp., further evaluation is warranted with blood cultures and a repeat echocardiogram as well as additional abdominal/pelvis imaging. Repeat paracentesis with positive culture could indicate a complication such as an abscess formation or continued reinfection via translocation. At the current time, the patient has been out of the hospital for more than six months, and he has experienced no apparent complications.

This case presents an interesting finding of Granulicatella spp. as an infectious agent involved in bacterascites with potential to progress to spontaneous bacterial peritonitis that has not been previously described in the literature. Clinical suspicion and testing for Granulicatella spp. in peritoneal fluid may help us to learn more about this commensal organism of the GI tract and its pathogenicity and response to therapy. We would recommend serial paracenteses with monitoring for clearance of the organism from the fluid and/or development of laboratory confirmed neutrocytic SBP for future cases prior to initiation of therapy.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

References

M. D. Collins and P. A. Lawson, “The genus Abiotrophia (Kawamura et al.) is not monophyletic: proposal of Granulicatella gen. nov., Granulicatella adiacens comb. nov., Granulicatella elegans comb. nov. and Granulicatella balaenopterae comb. nov,” International Journal of Systematic and Evolutionary Microbiology, vol. 50, no. 1, pp. 365–369, 2000.

J. S. Cargill, K. S. Scott, D. Gascoyne-Binzi, and J. A. T. Sandoe, “Granulicatella infection: diagnosis and management,” Journal of Medical Microbiology, vol. 61, no. 6, pp. 755–761, 2012.

S.-H. Chang, C.-C. Lee, S.-Y. Chen, I.-C. Chen, M.-R. Hsieh, and S.-C. Chen, “Infectious intracranial aneurysms caused by Granulicatella adiacens,” Diagnostic Microbiology and Infectious Disease, vol. 60, no. 2, pp. 201–204, 2008.

A. Jeng, J. Chen, and T. Katsivas, “Prosthetic valve endocarditis from Granulicatella adiacens (nutritionally variant streptococci),” Journal of Infection, vol. 51, no. 3, pp. e125–e129, 2005.

C.-H. Lin and R.-B. Hsu, “Infective endocarditis caused by nutritionally variant streptococci,” American Journal of the Medical Sciences, vol. 334, no. 4, pp. 235–239, 2007.

A. Perkins, S. Osorio, M. Serrano et al., “A case of endocarditis due to Granulicatella adiacens,” Clinical Microbiology and Infection, vol. 9, no. 6, pp. 576–577, 2003.

O. Rosenthal, A. Woywodt, P. Kirschner, and H. Haller, “Vertebral osteomyelitis and endocarditis of a pacemaker lead due to Granulicatella (Abiotrophia) adiacens,” Infection, vol. 30, no. 5, pp. 317–319, 2002.

K. E. Vandana, C. Mukhopadhyay, N. R. Rau, V. Ajith, and P. Rajath, “Native valve endocarditis and femoral embolism due to Granulicatella adiacens: a rare case report,” Brazilian Journal of Infectious Diseases, vol. 14, no. 6, pp. 634–636, 2010.

K. Padmaja, V. Lakshmi, S. Subramanian, M. Neeraja, S. R. Krishna, and O. Sai Satish, “Infective endocarditis due to Granulicatella adiacens: a case report and review,” Journal of Infection in Developing Countries, vol. 8, no. 4, pp. 548–550, 2014.

V. Garibyan and D. Shaw, “Bivalvular endocarditis due to Granulicatella adiacens,” American Journal of Case Reports, vol. 14, pp. 435–438, 2013.

T. S. Shailaja, K. A. Sathiavathy, and G. Unni, “Infective endocarditis caused by Granulicatella adiacens,” Indian Heart Journal, vol. 65, no. 4, pp. 447–449, 2013.

M. J. Bizzarro, D. A. Callan, P. A. Farrel, L.-M. Dembry, and P. G. Gallagher, “Granulicatella adiacens and early-onset sepsis in neonate,” Emerging Infectious Diseases, vol. 17, no. 10, pp. 1971–1973, 2011.

M. Altay, H. Akay, E. Yildiz, and M. Duranay, “A novel agent of peritoneal dialysis-related peritonitis: Granulicatella adiacens,” Peritoneal Dialysis International, vol. 28, no. 1, pp. 96–97, 2008.

E. Cerceo, J. D. Christie, I. Nachamkin, and E. Lautenbach, “Central nervous system infections due to Abiotrophia and Granulicatella species: an emerging challenge?” Diagnostic Microbiology and Infectious Disease, vol. 48, no. 3, pp. 161–165, 2004.

C. Biermann, G. Fries, P. Jehnichen, S. Bhakdi, and M. Husmann, “Isolation of Abiotrophia adiacens from a brain abscess which developed in a patient after neurosurgery,” Journal of Clinical Microbiology, vol. 37, no. 3, pp. 769–771, 1999.

J. L. del Pozo, E. Garcia-Quetglas, S. Hernaez et al., “Granulicatella adiacens breast implant-associated infection,” Diagnostic Microbiology and Infectious Disease, vol. 61, no. 1, pp. 58–60, 2008.

R. Fukuda, M. Oki, A. Ueda et al., “Vertebral osteomyelitis associated with Granulicatella adiacens,” Tokai Journal of Experimental and Clinical Medicine, vol. 35, no. 4, pp. 126–129, 2010.

M. J. Hepburn, S. L. Fraser, T. A. Rennie, C. M. Singleton, and B. Delgado Jr., “Septic arthritis caused by Granulicatella adiacens: diagnosis by inoculation of synovial fluid into blood culture,” Rheumatology International, vol. 23, no. 5, pp. 255–257, 2003.

C. A. Ku, B. Forcina, P. R. LaSala, and J. Nguyen, “Granulicatella adiacens, an unusual causative agent in chronic dacryocystitis,” Journal of Ophthalmic Inflammation and Infection, vol. 5, article 12, 2015.

B. W. C. Sim, R. M. Koo, C. Hawkins, F. Bowden, and A. Watson, “Granulicatella adiacens subacute bacterial endocarditis as the underlying cause of type II mixed cryoglobulinaemia,” BMJ Case Reports, vol. 2015, Article ID 206091, 2015.

F. Mougari, H. Jacquier, B. Berçot et al., “Prosthetic knee arthritis due to Granulicatella adiacens after dental treatment,” Journal of Medical Microbiology, vol. 62, no. 10, pp. 1624–1627, 2013.

B. Swain and S. Otta, “Granulicatella adiacens—an unusual causative agent for carbuncle,” Indian Journal of Pathology and Microbiology, vol. 55, no. 4, pp. 609–610, 2012.

J. C. Gardenier, T. Hranjec, R. G. Sawyer, and H. Bonatti, “Granulicatella adiacens bacteremia in an elderly trauma patient,” Surgical Infections, vol. 12, no. 3, pp. 251–253, 2011.

J. Such and B. A. Runyon, “Spontaneous bacterial peritonitis,” Clinical Infectious Diseases, vol. 27, no. 4, pp. 669–674, 1998.

B. A. Runyon, “Management of adult patients with ascites due to cirrhosis: an update 2012,” AASLD Practice Guideline, AASLD, 2012.